No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine / metabolism
-
Aged
-
Caffeine* / administration & dosage
-
Caffeine* / adverse effects
-
Caffeine* / pharmacokinetics
-
Drug Monitoring / methods
-
Dyspnea* / diagnosis
-
Dyspnea* / drug therapy
-
Dyspnea* / physiopathology
-
Female
-
Humans
-
Male
-
Middle Aged
-
Myocardial Ischemia* / drug therapy
-
Myocardial Ischemia* / metabolism
-
Myocardial Ischemia* / physiopathology
-
Patient Reported Outcome Measures
-
Purinergic P2Y Receptor Antagonists / administration & dosage
-
Purinergic P2Y Receptor Antagonists / adverse effects
-
Purinergic P2Y Receptor Antagonists / pharmacokinetics
-
Ticagrelor* / administration & dosage
-
Ticagrelor* / adverse effects
-
Ticagrelor* / pharmacokinetics
Substances
-
Purinergic P2Y Receptor Antagonists
-
Caffeine
-
Ticagrelor
-
Adenosine
Associated data
-
ClinicalTrials.gov/NCT02311088